The Influence of Malnutrition, Diabetes Mellitus, and Helminth Infections on Biosignatures in Latent Tuberculosis in a South Indian Population
NCT04526613 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 626
Last updated 2026-03-12
Summary
About 2 billion people worldwide are infected with tuberculosis (TB). Ninety percent of those people have latent TB infection (LTBI). Risk factors like malnutrition, diabetes mellitus (DM), and helminth infection can affect the development of active TB. Researchers want to study LTBI individuals with these issues to see how they may contribute to a person s higher risk for developing active TB. This study will take place in Chennai, India.
Objective:
To estimate the prevalence of malnutrition, DM, and helminth infections in people with LTBI.
Eligibility:
People age 14 65 with or without LTBI.
Design:
Participants will be screened with a medical history and physical exam focused on symptoms of active TB. Those who have TB symptoms will not take part in the study. Those who do not have TB symptoms will have a physical exam with vital signs, height, and weight. They will give blood and stool samples.
Participants will be assigned to 1 of 6 groups. They will repeat some of the screening tests. They will give urine samples. Some groups will have a chest X-ray. Some groups will have an ultrasound of the abdomen.
Participants will complete a survey about their history of smoking and drug and alcohol use.
Participants will have data collected about their nutritional status and body composition. Their skinfold thickness, ratio of waist/hip circumference, and grip strength will be measured.
Participants with DM, malnutrition, or helminth infection will be given standard of care or referred for follow-up treatment.
Participation will last up to 6 months.
...
Conditions
- Mycobacterium Tuberculosis
- LTBI (Latent TB Infection)
- Malnutrition
- Diabetes Mellitus
- Helminth Infections
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Principal Investigators
-
Thomas B Nutman, M.D. · National Institute of Allergy and Infectious Diseases (NIAID)
Eligibility
- Min Age
- 14 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-04-19
- Primary Completion
- 2026-03-11
- Completion
- 2026-03-11
Countries
- India
Study Locations
More Related Trials
-
The Impact of Malnutrition on Immune Responses to Tuberculosis
NCT05044910 ·Status: ACTIVE_NOT_RECRUITING
-
Blood Tuberculosis DNA Levels to Monitor Tuberculosis Treatment
NCT06845618 ·Status: RECRUITING
-
Training Protocol on the Natural History of Tuberculosis
NCT01212003 ·Status: RECRUITING
-
Immune Responses to Mycobacterium Tuberculosis (Mtb) in People With Latent Tuberculosis Infection With or Without Concomitant Helminth Infection
NCT02225158 ·Status: TERMINATED
-
Immune Response to Mycobacterium Tuberculosis Infection
NCT00257907 ·Status: COMPLETED
-
Impact of LTBI Treatment on Glucose Tolerance and Chronic Inflammation
NCT04830462 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis
NCT04930978 ·Status: RECRUITING
-
Brief Bactericidal Activity of Anti-Tuberculosis Drugs
NCT02236078 ·Status: COMPLETED ·Phase: PHASE1
-
Potential Role of Microbiome in Tuberculosis
NCT04985994 ·Status: COMPLETED
-
The Role of a Mycobacterium Growth Inhibition Assay to Quantify Host Immune Control of M. Tuberculosis
NCT06580639 ·Status: RECRUITING
-
Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients
NCT05571735 ·Status: RECRUITING
-
Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis
NCT04148053 ·Status: UNKNOWN
-
Effect of Weight and/or Obesity on Ethambutol Drug Concentrations
NCT01048697 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Analysis of Safety in Latent Tuberculosis Infection Prophylaxis Treatment
NCT04655794 ·Status: UNKNOWN
-
Lung Innate Immunity and Microbiome After Tuberculosis Exposure
NCT06526689 ·Status: RECRUITING
-
Identifcation of Biomarkers for Active Pulmonary Tuberculosis
NCT04490746 ·Status: UNKNOWN
-
Diagnostic Utility of Mycobacterium Tuberculosis Cell-free DNA
NCT06439810 ·Status: RECRUITING
-
Expression of Tuberculosis in the Lung
NCT00201253 ·Status: COMPLETED
-
Iron Absorption and Utilization During Tuberculosis and After Treatment
NCT02176772 ·Status: COMPLETED
-
Clinical Study of Recombinant Mycobacterium Tuberculosis ESAT6-CFP10 Allergen
NCT02623556 ·Status: COMPLETED ·Phase: PHASE3
-
New Strategies for Assessment of the Persistence of Viable Bacilli in Latent and Active Tuberculosis
NCT05621343 ·Status: RECRUITING
-
The Molecular Mechanism and the Role of NRAMP 1gene on Tuberculosis in Taiwan Aboriginal Tribes Population
NCT00266383 ·Status: COMPLETED
-
Efficacy and Safety of Immunomodulator as an Adjunct Therapy in New Pulmonary Tuberculosis(Category I) Patients.
NCT00341328 ·Status: COMPLETED ·Phase: PHASE3
-
Immunobiology of Diabetes and Tuberculosis
NCT00568854 ·Status: TERMINATED ·Phase: NA
-
Determining Risk in Latent Tuberculosis
NCT01571739 ·Status: TERMINATED